May 23, 2026 - 17:27

Warren Buffett's Berkshire Hathaway has quietly shifted a significant chunk of its investment focus toward artificial intelligence. According to the latest filings, a staggering 37.4% of the conglomerate's $330 billion equity portfolio is now concentrated in just three AI-driven companies. While Buffett has historically been cautious about tech hype, his team appears to be betting big on the sector's long-term potential.
The three stocks in question are Apple, Amazon, and a smaller but rapidly growing position in a company that recently caught Berkshire's eye. In a surprising move, Berkshire more than tripled its stake in one of these holdings during the last quarter, signaling a strong vote of confidence. Apple remains the heavyweight, accounting for the lion's share of the portfolio, but the increased allocation to the third name suggests Berkshire sees value beyond the usual consumer tech giants.
This concentration is unusual for Berkshire, which typically spreads its bets across insurance, railroads, and utilities. The shift reflects a broader market reality: AI is no longer a niche play but a core driver of earnings for major corporations. Whether this bet pays off depends on how quickly these companies can monetize their AI investments. For now, Berkshire is all in, with over a third of its firepower riding on three names.
November 20, 2026 - 02:05
Docusign to Release Third Quarter Financial Results on December 3, 2026Docusign has announced that it will share its financial results for the third quarter of fiscal 2027 after the U.S. markets close on Thursday, December 3, 2026. Following the release, the company...
November 19, 2026 - 01:35
Royal Gold Expands Board with Mining Veteran Harry Kenyon-SlaneyDENVER, November 18, 2026--Royal Gold has taken a significant step in enhancing its leadership by appointing Harry Kenyon-Slaney to its Board of Directors. Kenyon-Slaney brings a wealth of...
November 18, 2026 - 00:46
Ramon.Space Secures $124 Million to Boost Space ComputingRamon.Space has successfully raised $124 million in a Series B funding round aimed at enhancing its onboard computing systems tailored for the space industry. This significant investment will...
November 17, 2026 - 09:36
Harbour BioMed Welcomes Dr. Sanjay Keswani as Neuroscience Scientific AdvisorHarbour BioMed has announced the addition of Dr. Sanjay Keswani to its team as a Scientific Advisor in the field of Neuroscience. Dr. Keswani brings a wealth of experience and expertise, which will...